Evidence map›Paper›PMID 32685561›Full record

ArticleJournal of diabetes research2020

Prevalence and Determinants of Peripheral Neuropathy among Type 2 Adult Diabetes Patients Attending Jimma University Medical Center, Southwest Ethiopia, 2019, an Institutional-Based Cross-Sectional Study.

Daba Abdissa, Nigusse Hamba, Kumsa Kene, Deriba Abera Bedane, Guluma Etana, Dassalegn Muleta, Asfaw Gerbi

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Daba AbdissaDepartment of Biomedical Sciences (Clinical Anatomy), College of Medical Sciences, Institute of Health Sciences, Jimma University, Ethiopia.ORCID https://orcid.org/0000-0002-2979-7450
Nigusse HambaDepartment of Biomedical Sciences (Clinical Anatomy), College of Medical Sciences, Institute of Health Sciences, Jimma University, Ethiopia.
Kumsa KeneDepartment of Biomedical Sciences (Medical Biochemistry), College of Medical Sciences, Institute of Health Sciences, Jimma University, Ethiopia.
Deriba Abera BedaneDepartment of Biomedical Sciences (Medical Physiology), College of Medical Sciences, Institute of Health Sciences, Jimma University, Ethiopia.
Guluma EtanaDepartment of Biomedical Sciences (Clinical Anatomy), College of Medical Sciences, Wollega University, Ethiopia.ORCID https://orcid.org/0000-0001-5742-8268
Dassalegn MuletaDepartment of Medical laboratory Sciences (Medical Microbiology), College of Health Sciences, Mizan-Tepi University, Ethiopia.
Asfaw GerbiDepartment of Biomedical Sciences (Clinical Anatomy), College of Medical Sciences, Institute of Health Sciences, Jimma University, Ethiopia.
Jimma University · ETMizan Tepi University · ETWollega University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes chronic complications are major causes of morbidity and mortality, among which diabetic peripheral neuropathy (DPN) stands out. One of the tools to screen DPN is the Michigan neuropathy screening instrument. However, there is no data compiled using this tool to assess the prevalence and its determinants in Jimma. So, the aim of this study was to assess the prevalence of DPN and its determinants among patients with diabetes mellitus at Jimma University Medical Center

resultsThe mean age of participants was 50.1 ± 14.28 years. The study finding showed that the prevalence of DPN was 53.6% among study participants. According to the multivariate logistic regression age above 40 years (AOR = 4.57; 95% CI: 1.50, 13.9), above 50 years (AOR = 6.5; 95% CI: 2.24, 18.79), duration of diabetes above 5 years (AOR = 3.06; 95% CI: 1.63, 5.77), duration above 10 years (AOR = 7.1; 95% CI: 2.99, 17.28), physical inactivity (AOR = 2.02; 95% CI: 1.14, 3.55), and smoking (current smoker AOR = 7.96, 95% CI: 3.22, 19.64; former smoker (AOR = 2.65; 95% CI: 1.22, 5.77) were independent predictors of DPN among study participants.

conclusionAlmost half of the study participants had DPN. Age above 40 years, diabetes duration of above 5 years, physical inactivity, and smoking were significantly associated with DPN. Early detection and appropriate interventions are important among patients with age above 40 years, physically inactive, smokers, and diabetes duration of above 5 years.

Indexed as

AdultAgedCross-Sectional StudiesDiabetes Mellitus, Type 2Diabetic NeuropathiesEthiopiaFemaleHumansMaleMiddle AgedPeripheral Nervous System DiseasesPrevalenceRisk Factors

Identifiers

PMID32685561
PMCPMC7341394
OpenAlexW3039301339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.